ExcelMab
About:
ExcelMab develops a series of anti-tumor bispecific antibody drugs for cancer patients.
Website: http://www.excelmab.com
Top Investors: Korea Investment Partners, CAS Investment Management, Med-Fine Capital, Elite Capital, Talent Capital
Description:
ExcelMab develops a series of anti-tumor bispecific antibody drugs for cancer patients.
Total Funding Amount:
10M CNY
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Guangzhou, Guangdong, China
Founded Date:
2016-01-01
Founders:
Chunxu Yang, Wenjun Zhang
Number of Employees:
11-50
Last Funding Date:
2020-03-12
IPO Status:
Private
Industries:
© 2025 bioDAO.ai